Scientists Discover Cancer-Driving RNA That Hijacks Protein Production in Liver Tumors

This groundbreaking research reveals how cancer cells exploit cellular machinery in unexpected ways, potentially opening new avenues for treating one of the deadliest cancers. Liver cancer remains a leading cause of cancer deaths worldwide, making novel therapeutic targets critically important for extending patient survival.

Researchers analyzed RNA molecules in hepatocellular carcinoma (HCC), focusing on variants with different starting sequences. They discovered SLCO2B1-isoN, an unusual RNA that cannot produce proteins due to its unique structure but instead functions as a regulatory molecule. This represents a fascinating example of cellular repurposing.

Using comprehensive molecular analysis and laboratory experiments, scientists found that SLCO2B1-isoN stabilizes the FMR1 protein, which normally regulates protein synthesis. When stabilized, FMR1 dramatically increases the cell's ability to manufacture proteins, providing cancer cells with the molecular building blocks needed for rapid growth and spread. Animal studies confirmed that targeting this RNA effectively reduced tumor growth and metastasis.

The implications extend beyond liver cancer treatment. This discovery highlights how cells can evolve dual-purpose molecules that both code for proteins and regulate cellular processes. Understanding these mechanisms could lead to more precise cancer therapies that target specific RNA variants rather than entire genes. For longevity research, this work emphasizes the importance of protein homeostasis in preventing cancer, suggesting that interventions supporting healthy protein regulation might reduce cancer risk as we age.

However, this research focused specifically on liver cancer, and the therapeutic potential requires extensive clinical testing before human applications.